Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic

Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic

The spread of the COVID-19 pandemic posed a serious challenge for scientific and clinical medical institutions in terms of research for new multiple sclerosis (MS) treatments. In this review we discuss the associations between coronavirus infection and MS and provide data on the features of MS patho...

Full description

Bibliographic Details
Main Authors: E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-09-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
multiple sclerosis
clinical trials
ethical aspects
covid-19
Online Access:https://nnp.ima-press.net/nnp/article/view/1652

Similar Items

Similar Items